Labeler · US market

Novo Nordisk

Novo Nordisk is a US drug labeler with US FDA registrations covering 28 drug concepts (25 currently active) across 145 packages. It is currently the only active US supplier of 15 drugs. The company files with FDA under 3 name variants, merged into this profile.

Also files as: Novo Nordisk Pharma, Inc. · Novo Nordisk Pharmaceutical Industries, LP

ACTIVE — US

openFDA · updated weekly

Labeler codes0169 · 73070

Active drugs25

Registrations98 active / 110

Packages145

Sole supplier of15 drugs

Portfolio28 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Insulin Aspart injection, solution	rx	9	12	SUPPLYING
Semaglutide injection, solution	rx	18	12	SUPPLYING
Antihemophilic Factor (Recombinant), Glycopegylated-Exei kit	other	7	10	SUPPLYING
Insulin Degludec injection, solution	rx	6	9	SUPPLYING
Human Insulin injection, suspension	otc	4	8	SUPPLYING
Coagulation Factor Viia (Recombinant) kit	other	8	8	SUPPLYING
Somatropin injection, solution	rx	4	8	SUPPLYING
Oral Semaglutide tablet	rx	6	8	SUPPLYING
Coagulation Factor Ix Recombinant, Glycopegylated kit	rx	4	7	SUPPLYING
Insulin Aspart injection, suspension	rx	6	6	SUPPLYING
Antihemophilic Factor (Recombinant) kit	other	6	6	SUPPLYING
Somapacitan-Beco injection, solution	rx	3	6	SUPPLYING
Insulin Aspart Injection injection, solution	rx	3	6	SUPPLYING
Semaglutide tablet	rx	4	5	SUPPLYING
Liraglutide injection	rx	1	4	SUPPLYING
Human Insulin injection, solution	otc	2	4	SUPPLYING
Nedosiran injection, solution	rx	3	3	SUPPLYING
Insulin Icodec-Abae injection, solution	rx	3	3	SUPPLYING
Concizumab injection, solution	rx	3	3	SUPPLYING
Estradiol insert	rx	1	3	SUPPLYING
Liraglutide injection, solution	rx	1	3	SUPPLYING
Insulin Aspart injection, solution	rx	1	2	SUPPLYING
Water Injection injection, solution	rx	1	1	SUPPLYING
Insulin Degludec And Liraglutide injection, solution	rx	1	1	SUPPLYING
Coagulation Factor Xiii A-Subunit (Recombinant) kit	other	1	1	SUPPLYING
Dasiglucagon injection, solution	rx	2	4	DISCONTINUED
Insulin Detemir injection, solution	rx	1	1	DISCONTINUED
Macimorelin Acetate granule, for solution	rx	1	1	DISCONTINUED

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

+5 more

At a glance

TypeLabeler
Labeler codes0169, 73070
Filing names3
Drugs (active)25
Drugs (all time)28
US registrations110
Packages145

Recent events

Shortages, recalls, and registration changes across all filing names.

Jun 4, 2026
RESOLVEDShortage resolved: Semaglutide Tablet (Novo Nordisk, Inc.)
Jun 4, 2026
SHORTAGEDrug shortage: Semaglutide Tablet (Novo Nordisk, Inc.)
Dec 19, 2025
RECALLRecall (Class II): Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
Dec 19, 2025
RECALLRecall (Class II): Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…
Nov 14, 2025
RESOLVEDShortage resolved: Somatropin Injection (Novo Nordisk, Inc.)
Nov 14, 2025
SHORTAGEDrug shortage: Somatropin Injection (Novo Nordisk, Inc.)
Jul 21, 2025
RESOLVEDShortage resolved: Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension (Novo Nordisk, Inc.)
Jul 21, 2025
SHORTAGEDrug shortage: Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension (Novo Nordisk, Inc.)

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile (see “Also files as” above); figures cover the entity across all its filing names.